There has been a reported breakthrough in the race to develop a Covid-19 vaccine by scientists at Oxford University. An immune response to the new vaccine called ChAdOx1 nCoV-19 has indicated a strong “double defence”, whereby both antibodies and “killer” T-cells were reported to have been present in blood samples from volunteers in the first human phase of testing. The information was provided to The Telegraph by a senior source. Further media coverage will be reported on these developments on Monday 20th July.
Latest posts by Hippocratic Post (see all)
- Combination of drugs could prevent thousands of heart attacks - 21st April 2025
- UQ Study Links Poor Teen Diets to Heavy Social Media Use - 21st April 2025
- Gut microbiome could delay onset of type 1 diabetes - 3rd April 2025